Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

NCT02641158 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02641158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02641158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
May 9, 2018
Enrollment
422 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hepatitis c, hiv, substance use